Remission of an Intracardiac Melanoma Metastasis after Tremelimumab Therapy
Tremelimumab is a fully human monoclonal antibody specific for human cytotoxic T lymphocyte-associated antigen 4. Administration of tremelimumab to patients with locally advanced and metastatic melanoma has resulted in a subset of patients with durable objective tumour regressions. Our echocardiogra...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
S. Karger AG
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975197/ |
| id |
pubmed-3975197 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-39751972014-04-04 Remission of an Intracardiac Melanoma Metastasis after Tremelimumab Therapy Spethmann, Sebastian Trefzer, Uwe Knebel, Fabian Published online: February, 2014 Tremelimumab is a fully human monoclonal antibody specific for human cytotoxic T lymphocyte-associated antigen 4. Administration of tremelimumab to patients with locally advanced and metastatic melanoma has resulted in a subset of patients with durable objective tumour regressions. Our echocardiographic images impressively show the effects of this new antibody in a patient with cardiac metastatic malignant melanoma. S. Karger AG 2014-02-15 /pmc/articles/PMC3975197/ /pubmed/24707247 http://dx.doi.org/10.1159/000360127 Text en Copyright © 2014 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions. |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
Spethmann, Sebastian Trefzer, Uwe Knebel, Fabian |
| spellingShingle |
Spethmann, Sebastian Trefzer, Uwe Knebel, Fabian Remission of an Intracardiac Melanoma Metastasis after Tremelimumab Therapy |
| author_facet |
Spethmann, Sebastian Trefzer, Uwe Knebel, Fabian |
| author_sort |
Spethmann, Sebastian |
| title |
Remission of an Intracardiac Melanoma Metastasis after Tremelimumab Therapy |
| title_short |
Remission of an Intracardiac Melanoma Metastasis after Tremelimumab Therapy |
| title_full |
Remission of an Intracardiac Melanoma Metastasis after Tremelimumab Therapy |
| title_fullStr |
Remission of an Intracardiac Melanoma Metastasis after Tremelimumab Therapy |
| title_full_unstemmed |
Remission of an Intracardiac Melanoma Metastasis after Tremelimumab Therapy |
| title_sort |
remission of an intracardiac melanoma metastasis after tremelimumab therapy |
| description |
Tremelimumab is a fully human monoclonal antibody specific for human cytotoxic T lymphocyte-associated antigen 4. Administration of tremelimumab to patients with locally advanced and metastatic melanoma has resulted in a subset of patients with durable objective tumour regressions. Our echocardiographic images impressively show the effects of this new antibody in a patient with cardiac metastatic malignant melanoma. |
| publisher |
S. Karger AG |
| publishDate |
2014 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975197/ |
| _version_ |
1612074003725287424 |